guest ::
000945848 001__ 945848 000945848 005__ 20230701050303.0 000945848 0247_ $$2HSB$$aeva504963 000945848 0247_ $$2ISSN$$a1522-8517 000945848 0247_ $$2ISSN$$a1523-5866 000945848 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85134974137 000945848 0247_ $$2WOS$$aWOS:000807656300001 000945848 0247_ $$2doi$$a10.1093/neuonc/noac131 000945848 0247_ $$2pmid$$apmid:35674736 000945848 037__ $$aRWTH-CONV-250801 000945848 041__ $$aEnglish 000945848 1001_ $$aGalldiks, Norbert$$b0$$eCorresponding author 000945848 245__ $$aInvestigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group$$honline, print 000945848 260__ $$aOxford$$bOxford Univ. Press$$c2022 000945848 3367_ $$00$$2EndNote$$aJournal Article 000945848 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal 000945848 3367_ $$2BibTeX$$aARTICLE 000945848 3367_ $$2DRIVER$$aarticle 000945848 3367_ $$2DataCite$$aOutput Types/Journal article 000945848 3367_ $$2ORCID$$aJOURNAL_ARTICLE 000945848 591__ $$aDenmark 000945848 591__ $$aGermany 000945848 591__ $$aItaly 000945848 591__ $$aSwitzerland 000945848 591__ $$aUSA 000945848 7001_ $$0P:(DE-82)013919$$aLangen, Karl-Josef$$b1$$urwth 000945848 7001_ $$aAlbert, Nathalie L.$$b2 000945848 7001_ $$aLaw, Ian$$b3 000945848 7001_ $$aKim, Michelle M.$$b4 000945848 7001_ $$aVillanueva-Meyer, Javier E.$$b5 000945848 7001_ $$aSoffietti, Riccardo$$b6 000945848 7001_ $$aWen, Patrick Y.$$b7 000945848 7001_ $$aWeller, Michael$$b8 000945848 7001_ $$aTonn, Joerg C.$$b9 000945848 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noac131$$n11$$p1815-1826$$tNeuro-Oncology : official journal of the World Federation of Neuro-Oncology$$v24$$x1522-8517 000945848 909CO $$ooai:publications.rwth-aachen.de:945848$$pVDB 000945848 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)013919$$aRWTH Aachen$$b1$$kRWTH 000945848 9141_ $$y2022 000945848 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0 000945848 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2021$$d2022-11-08 000945848 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-08 000945848 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-08 000945848 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-08 000945848 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-08 000945848 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-08 000945848 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-08 000945848 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-08$$wger 000945848 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-08 000945848 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bNEURO-ONCOLOGY : 2021$$d2022-11-08 000945848 9201_ $$0I:(DE-82)532500-2_20140620$$k532500-2$$lKlinik und Lehrstuhl für Nuklearmedizin$$x0 000945848 9201_ $$0I:(DE-82)532500-3_20140620$$k532500-3$$lLehr- und Forschungsgebiet Experimentelle und klinische Nuklearmedizin (FZ Jülich)$$x1 000945848 961__ $$z2023-03-21 000945848 970__ $$aeva504963 000945848 980__ $$aI:(DE-82)532500-2_20140620 000945848 980__ $$aI:(DE-82)532500-3_20140620 000945848 980__ $$aUNRESTRICTED 000945848 980__ $$aVDB 000945848 980__ $$ajournal